Risk Assessment of Triflumezopyrim and Imidacloprid in Rice through an Evaluation of Residual Data

Author:

Zhang Yue,Wang Meiran,Silipunyo Thiphavanh,Huang Haizhu,Yin Qingchun,Han Bingjun,Wang Mingyue

Abstract

Triflumezopyrim, a novel mesoionic insecticide used to control planthoppers, is a potential substitute for imidacloprid. In this study, triflumezopyrim and imidacloprid residues in rice were determined using a quick, easy, cheap, effective, rugged, and safe procedure combined with ultra-high-performance liquid chromatography–tandem mass spectrometry. The limit of quantification of both triflumezopyrim and imidacloprid was 0.01 mg kg−1, and the average recovery values were 94–104% and 91–106%, with relative standard deviations (RSDs) of 1.1–1.4% and 2.1–3.4% (n = 5), respectively. The consumer protection level was assessed by calculating the theoretical maximum daily intake using the reported maximum residue limits of triflumezopyrim and imidacloprid. The established method was successfully applied to 200 commercial rice samples collected from four provinces in China, and their potential public health risks were assessed using triflumezopyrim and imidacloprid residues. The risk associated with triflumezopyrim and imidacloprid dietary intake was assessed by calculating the national estimated short-term intake and the acute reference dose percentage (%ARfD). The results show that the theoretical maximum daily intake (NEDI) values of triflumezopyrim and imidacloprid in different age and gender groups were 0.219–0.543 and 0.377–0.935 μg kg−1 d−1 bw, and the risk quotient (RQ) values were 0.188–0.467% and 0.365–0.906%, respectively. The acute reference dose (%ARfD) of triflumezopyrim and imidaclopridin ranged from 0.615 to 0.998% and from 0.481 to 0.780%, respectively.

Funder

key laboratory of tropical fruits and vegetables quality and safety for state market regulation

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3